News
1d
Flow Space on MSNA New Option for Hot Flashes: What the Research Says About ElinzanetantHot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...
2d
MedPage Today on MSNNon-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast CancerCHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...
California lawmakers are pushing a bill that would require doctors to receive more training on menopause, aiming to address ...
Discover how scientists can delay menopause by 10+ years using rapamycin and tissue preservation. Revolutionary options.
Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...
There are estrogen receptors in your breast tissue, which means a drop in estrogen can lead to breast changes, Dr. Streicher ...
The trial focused on a drug called Duavee, a combination of conjugated estrogens and bazedoxifene, which is already approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results